Longitudinal Follow-up of Individuals with Opioid Use Disorder

The primary aim of the Longitudinal Follow-up of Individuals with Opioid Use Disorder (LFU-OUD) study is to establish initial and long-term feasibility of participant registration, retention, engagement, and data collection in a longitudinal study, linked to participating CTN clinical trials, that follows individuals with OUD. Secondary aims will address key scientific questions using core follow-up data and trial-specific longitudinal data elements for participating trials. Scientific inquiries will be geared toward investigating questions such as: characterizing the long-term course of OUD (outcomes of opioid and other substance use, mortality, functional outcomes and engagement in treatment); evaluating treatment participation status at follow-up, treatment retention over time, and effects of each type of opioid replacement treatment on opioid use and other recovery milestones; and identifying predictors of long-term OUD outcomes (treatment-related factors (e.g., type of MOUD), participant sociodemographic characteristics, and participant clinical factors (e.g., co-occurring psychiatric disorders).

CTN Protocol ID: 
CTN-0126
Status: 
Active

Principal Investigator(s)

Kathryn Hefner, Ph.D.

Senior Project Leader-Scientist
The Emmes Company

401 North Washington Street, Suite 700
Rockville, MD 20850
United States

R. Kathryn McHugh, Ph.D.

Director, Stress, Anxiety, and Substance Use Laboratory; Associate Psychologist, Division of Alcohol, Drugs, and Addiction
McClean Hospital

115 Mill Street
Belmont, MA 02478
United States

Rebecca Ottesen

Biostatistician Manager
Emmes Company, LLC

401 North Washington Street, Suite 700
Rockville, MD 20850
United States